A phase I study of the trinuclear platinum compound, BBR 3464, in combination with protracted venous infusional 5-fluorouracil in patients with advanced cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/14605864

Download in:

View as

General Info

PMID
14605864